NEOADJUVANT CHEMOTHERAPY WITH OXALIPLATIN AND FLUOROPYRIMIDINE VERSUS UPFRONT SURGERY FOR LOCALLY ADVANCED COLON CANCER: THE RANDOMIZED, PHASE III OPTICAL TRIAL. Novembre 5, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
NEOADJUVANT DOCETAXEL, OXALIPLATIN, AND S-1 PLUS SURGERY AND ADJUVANT S-1 FOR RESECTABLE ADVANCED GASTRIC CANCER: UPDATED OVERALL SURVIVAL OUTCOMES FROM PHASE III PRODIGY. Ottobre 28, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
ELACESTRANT (ORAL SELECTIVE ESTROGEN RECEPTOR DEGRADER) VERSUS STANDARD ENDOCRINE THERAPY FOR ESTROGEN RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED BREAST CANCER: RESULTS FROM THE RANDOMIZED PHASE III EMERALD TRIAL. Ottobre 21, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
TRASTUZUMAB DERUXTECAN AFTER ENDOCRINE THERAPY IN METASTATIC BREAST CANCER. Ottobre 14, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
AICRO-MENTI A CONTATTO 8 NOVEMBRE 2024 ROMA-MILANO Ottobre 10, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME, PATROCINIO/da Luisa
NEOADJUVANT NIVOLUMAB AND IPILIMUMAB IN RESECTABLE STAGE III MELANOMA. Ottobre 7, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
OVERALL SURVIVAL WITH PEMBROLIZUMAB IN EARLY-STAGE TRIPLE-NEGATIVE BREAST CANCER. Ottobre 1, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
8°GIORNATA NAZIONALE SIPO-CONVEGNO INTERREGIONALE SIPO VENETO-TRENTINO ALTO ADIGE 30 SETTEMBRE 2024, BOLZANO Settembre 24, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME, PATROCINIO/da Luisa
CORTICOSTEROIDS FOR IMMUNE-RELATED ADVERSE EVENTS AND CHECKPOINT INHIBITOR EFFICACY: ANALYSIS OF SIX CLINICAL TRIALS. Settembre 23, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
